Abstract:Objective - Although serum amyloid A ( SAA) is a useful biomarker of coronary artery disease ( CAD), its direct role in procoagulation is obscure. This study investigates the impact of SAA on the expression and activity of tissue factor ( TF) and tissue factor pathway inhibitor ( TFPI) in endothelial cells.Methods and Results - SAA was found to disturb the balance of TF and TFPI expression and activity in human endothelial cells. SAA ( 20 mu g/mL) markedly induced TF expression between 4 to 8 hours in both protein and mRNA levels, as well as TF activity. Conversely, incubation of SAA ( 20 mu g/mL) for 24 and 48 hours was found to significantly inhibit TFPI secretion, transcription, and activity. Pretreatment with formyl peptide receptor- like 1 ( FPRL1) inhibitors ( Pertussis toxin and WRWWWW) could block the SAA effects on TF and TFPI. Furthermore, pretreatment with the respective specific mitogen- activated protein kinase ( MAPK) inhibitors ( SB203580, PD98059, and SP600125) and NF kappa B inhibitor ( Bay- 11 to 7082) could block SAA- dependent TF induction. SAA also directly induced activation of MAP kinases and NF kappa B.Conclusions - The stimulating effect of SAA was faster-acting on the expression and activity of TF and the inhibitory effect was slower- acting on TFPI. The effects are mediated through FPRL1, MAP kinases and NF kappa B.

Impact of Serum Amyloid A on Tissue Factor and Tissue Factor Pathway Inhibitor Expression and Activity in Endothelial Cells